The Environmental Polymorphisms Registry: a DNA resource to study genetic susceptibility loci

被引:0
|
作者
Patricia C. Chulada
Heather L. Vahdat
Richard R. Sharp
Tracy C. DeLozier
Paul B. Watkins
Susan N. Pusek
Perry J. Blackshear
机构
[1] National Institute of Environmental Health Sciences,Clinical Research Program
[2] Family Health International,Department of Bioethics
[3] Cleveland Clinic,General Clinical Research Center, Rm. 3005 Clinical Research Center
[4] Integrated Laboratory Systems,undefined
[5] Inc,undefined
[6] University of North Carolina Hospitals,undefined
来源
Human Genetics | 2008年 / 123卷
关键词
Personal Identification Number; North Carolina; Oversight Committee; General Clinical Research Center; National Bioethic Advisory Commission;
D O I
暂无
中图分类号
学科分类号
摘要
The National Institute of Environmental Health Sciences is establishing a DNA repository named the Environmental Polymorphisms Registry (EPR). The goal is to recruit 20,000 subjects from the greater Research Triangle Park region of North Carolina and collect a sample of each subject’s DNA for genetic study. Personal information is obtained from each EPR subject and linked to their sample in coded form. Once individuals with the genotypes of interest are identified, their samples are decoded, and their names and contact information are given to scientists for follow-up studies in which genotype is important. “Recruit-by-genotype” resources such as the EPR require a transparent consent process and rigorous human subjects protection measures. Unlike the EPR, most US DNA resources are anonymous. Once scientists identify potentially significant genetic variants, they must screen new populations to find individuals with the variants of interest to study. The EPR eliminates this time consuming and expensive step. In designing the EPR, consideration was given to achieving high response rates, minimizing attrition and maximizing usefulness for future research studies. Subjects are recruited from outpatient clinics in area medical centers as well as from the general population to ascertain individuals in diverse states of health. Data are collected on race, ethnicity, gender and age, and are monitored for demographic diversity. As of November 2007, 7,788 individuals have been recruited into the EPR and their DNA samples have been used in numerous genetic studies. EPR subjects have also been solicited for several follow-up studies with high response rates (>90%). The success of the EPR based on the number of subjects recruited and genetic studies underway, suggests that it will be a model for future DNA resources.
引用
收藏
页码:207 / 214
页数:7
相关论文
共 50 条
  • [41] Genetic Polymorphisms of Paraoxonase 1 and Susceptibility to Atherogenesis
    Grubisa, Ivana
    Otasevic, Petar
    Dimkovic, Nada
    Nedeljkovic, Ivana
    Toljic, Bosko
    Vucinic, Nada
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2013, 141 (9-10) : 629 - 633
  • [42] Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer
    Chacko, P
    Rajan, B
    Joseph, T
    Mathew, BS
    Pillai, MR
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 89 (01) : 15 - 21
  • [43] Cytokine genetic polymorphisms and susceptibility to periventricular leukomalacia
    Levene, M.
    Gopichandran, N.
    Ekbote, U.
    Simpson, N.
    Orsi, N.
    BIOLOGY OF THE NEONATE, 2006, 90 (04): : 282 - 282
  • [44] Caspase polymorphisms and genetic susceptibility to multiple myeloma
    Hosgood, H. Dean, III
    Baris, Dalsu
    Zhang, Yawei
    Zhu, Yong
    Zheng, Tongzhang
    Yeager, Meredith
    Welch, Robert
    Zahm, Shelia
    Chanock, Stephen
    Rothman, Nathaniel
    Lan, Qing
    HEMATOLOGICAL ONCOLOGY, 2008, 26 (03) : 148 - 151
  • [45] Host Genetic Polymorphisms Influencing Susceptibility to Dengue
    Gupta, Sudheer
    Agarwal, Ankita
    Biswas, Debasis
    DNA AND CELL BIOLOGY, 2018, 37 (10) : 805 - 807
  • [46] Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility
    Peng Zhao
    Peng Zou
    Lin Zhao
    Wei Yan
    Chunsheng Kang
    Tao Jiang
    Yongping You
    BMC Cancer, 13
  • [47] Role of genetic polymorphisms and ovarian cancer susceptibility
    Fasching, Peter A.
    Gayther, Simon
    Pearce, Leigh
    Schildkraut, Joellen M.
    Goode, Ellen
    Thiel, Falk
    Chenevix-Trench, Georgia
    Chang-Claude, Jenny
    Wang-Gohrke, Shan
    Ramus, Susan
    Pharoah, Paul
    Berchuck, Andrew
    MOLECULAR ONCOLOGY, 2009, 3 (02) : 171 - 181
  • [48] Genetic Polymorphisms in miRNAs and Susceptibility to Colorectal Cancer
    Wu, Yu
    Hao, Xiaoxiong
    Feng, Zili
    Liu, Yunsheng
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 71 (01) : 271 - 278
  • [49] Genetic polymorphisms, pesticides susceptibility and cancer risk
    Dialyna, I
    Dolapsakis, G
    Nikitovic, D
    Tzanakakis, G
    Tsatsakis, AM
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 254 - 254
  • [50] Genetic polymorphisms associated with susceptibility and outcome in ARDS
    Marshall, RP
    Webb, S
    Hill, MR
    Humphries, SE
    Laurent, GJ
    CHEST, 2002, 121 (03) : 68S - 69S